Education Program
Late-breaking sessions have been added to the CHEST 2008 program to present the latest developments in areas of chest medicine. Plan to attend these sessions for up-to-the-minute information. (Session details are subject to change. Check on-site signage for the most current information.)
Monday, October 27
The Surgeon General’s Call to Action to Prevent Deep Vein Thrombosis and Pulmonary Embolism
Are Heart Attacks a Side Effect of Anticholinergic Inhalers?
Tuesday, October 28
Centers for Medicare and Medicaid Services "Approved" Home Sleep Studies: Now What?
Wednesday, October 29
Critical Care Nephrology: What an Intensivist Should Know
Thursday, October 30
Overcoming Health Disparities: The Philadelphia Experience
Multistate Bronchoscopy Education Project: Trends From the 2-Year Project
A Preview of the ACCP Tobacco Dependence Treatment Toolkit, 3rd Edition
Monday, October 27
8:30 am - 9:45 am
Session ID 2947
Convention Center, 203 AB
The Surgeon General’s Call to Action to Prevent Deep Vein Thrombosis and Pulmonary Embolism
This presentation will review the US Surgeon General’s call to action and the human and economic costs of DVT and PE, as well as effective quality improvement in the prevention of venous thromboembolism. This call to action was based on the Surgeon General’s Workshop on Deep Vein Thrombosis, cosponsored by the National Heart, Lung, and Blood Institute of the National Institutes of Health.
Faculty
James M. Galloway, MD, FACP, FACC, FAHA
Assistant Surgeon General
Rear Admiral, US Public Health Service
Regional Health Administrator, Region V
[back]
10:30 am - 12:00 pm
Session ID 2997
Convention Center, Convention Center, Ballroom B
Are Heart Attacks a Side Effect of Anticholinergic Inhalers?
Most clinical practice guidelines for COPD currently recommend the daily use of either an anticholinergic inhaler or combo inhaler (high-dose inhaled corticosteroid plus long-acting β2-agonist) for those with an FEV1 below 50% predicted. More than $5 billion has been spent on inhalers for COPD—about half that for tiotropium inhalers, used by more than 8 million patients. Most pulmonologists only think of dry mouth and urinary retention as bothersome side effects of inhaled anticholinergics; however, large studies published in 2008 reported a significantly increased risk of cardiovascular deaths. These reports have prompted the manufacturer, distributors, and promoters of ipratropium and tiotropium to release the preliminary results of serious adverse events from their UPLIFT study. Investigators from all of these studies will summarize their results, and then discuss them, face-to-face, for the first time.
Chair
Paul L. Enright, MD, Tucson, AZ
Topics & Faculty
- Results from the Lung Health Study
Paul L. Enright, MD, Tucson, AZ
- Results From Boehringer's UPLIFT Study
Donald P. Tashkin, MD, FCCP, Los Angeles, CA
- Results From the National Veterans Affairs Database
Todd A. Lee, PharmD, Hines, IL
- A Systematic Review and Metaanalysis
Curt D. Furberg, MD, Winston-Salem, NC
- Comparing Conflicting Study Results: The Devil Is in the Details
R. Graham Barr, MD, New York, NY
- Panel Discussion and Rebuttals
Paul L. Enright, MD, Tucson, AZ
- Questions From the Audience
Paul L. Enright, MD, Tucson, AZ
[back]
Tuesday, October 28
4:15 pm - 5:45 pm
Session ID 2618
Convention Center, 108 B
Centers for Medicare and Medicaid Services "Approved" Home Sleep Studies: Now What?
This session will address the background and climate leading up to the decision by the Centers for Medicare and Medicaid Services (CMS) to approve home sleep testing (HST), as well as the ACCP’s role and comment to CMS regarding HST. Also reviewed in detail will be the national coverage determination and local coverage determinations, to date, and their implications.
Chair
Barbara A. Phillips, MD, FCCP, Lexington, KY
Topics & Faculty
- Introduction
Barbara A. Phillips, MD, FCCP, Lexington, KY
- CMS Decision To Approve Home Sleep Studies and ACCP Role
Peter C. Gay, MD, FCCP, Rochester, MN
- The National Coverage Determination and Its Implications
Barbara A. Phillips, MD, FCCP, Lexington, KY
- Local Coverage Determinations to Date and Their Implications
Charles W. Atwood, Jr., MD, FCCP, Pittsburgh, PA
[back]
Wednesday, October 29
2:30 pm - 4:00 pm
Session ID 2887
Convention Center, 114
Critical Care Nephrology: What an Intensivist Should Know
This session will address acute kidney injury and its pathophysiology, predictive scoring models (eg, RIFLE), biomarkers, and emerging strategies for following and/or predicting the course of acute kidney injury in the ICU. Interventions to be discussed include nondialytics and stem cells, and current, state-of-the-art renal replacement therapies and their applications.
Chair
Peter Spiro, MD, FCCP, Bronx, NY
Topics & Faculty
- Emerging Strategies and Use of Biomarkers in Predicting and Preventing Acute Renal Failure and the Application of Nondialytic Interventions
Sumit Mohan, MD, New York, NY
- Renal Replacement Therapy in the ICU: What’s New, What’s Optimal, and a Review of the Acute Renal Failure Trial Network (ATN) Study
Paul M. Palevsky, MD, FCCP, Sewickley, PA
- Acute Kidney Injury: Changing the Course of Renal Failure in the ICU
Howard L. Corwin, MD, Lebanon, NH
[back]
Thursday, October 30
8:00 am - 9:30 am
Session ID 2719
Convention Center, 107 AB
Overcoming Health Disparities: The Philadelphia Experience
For many years, Philadelphia has promoted innovative communication strategies to reduce health-care disparities in the community. These strategies provide the means for physicians to provide information prescriptions to their patients. The information available is culturally sensitive, health literacy-appropriate, and language-specific in ways that patients and families can understand and use to manage their health and access health-care services and resources. Public health and medical leaders have worked together in partnership with health professionals and community groups to develop community health information centers featuring personal health information navigators and a trusted Internet health portal: www.phillyhealthinfo.org. This session will offer background information and recent developments of how Philadelphia has used communication to overcome health disparities, along with presentations by, and reactions from, experienced leaders offering critical evaluation of the impact.
Chair
Allen I. Goldberg, MD, Master FCCP, Chicago, IL
Co-Chair
Alvin V. Thomas, Jr., MD, FCCP, Washington, DC
Discussant
Michelle Davis, PhD, Philadelphia, PA
Topics & Faculty
- Overcoming Health Disparities by Improving Access to Regional Health
Andrea Kenyon, Philadelphia, PA
- Working in and With the Community To Overcome Health-Care Disparities
Lawrence Robinson, MD, Philadelphia, PA
[back]
9:45 am - 11:15 am
Session ID 2686
Convention Center, 104 AB
Multistate Bronchoscopy Education Project: Trends From the 2-Year Project
The ACCP has sponsored a 2-year trial to track both practical and cognitive acquisition of bronchoscopy skills in first-year fellows. Two cohorts of first-year fellows were studied from seven institutions. The first cohort practiced best institutional educational practices for bronchoscopy. The second cohort followed a standardized curriculum for the practical and cognitive aspects of bronchoscopy learning. The results and trends from the two cohorts will be discussed.
Chair
Gordon H. Downie, MD, FCCP, Mt. Pleasant, TX
Co-Chair
Momen M. Wahidi, MD, FCCP, Durham, NC
Topics & Faculty
- The Multistate Bronchoscopy Education Project: Background, Rationale, and Methodolgy
Gordon H. Downie, MD, FCCP, Mt. Pleasant, TX
- The Multistate Bronchoscopy Education Project: Results and Analysis
Momen M. Wahidi, MD, FCCP, Durham, NC
- Bronchoscopy Education: Lessons Learned and the Future
Gordon H. Downie, MD, FCCP, Mt. Pleasant, TX
[back]
9:45 am - 11:15 am
Session ID 2684
Convention Center, 103 AB
A Preview of the ACCP Tobacco Dependence Treatment Toolkit, 3rd Edition
Participants will learn about the newly updated ACCP Tobacco Dependence Treatment Toolkit to recognize and effectively treat tobacco dependence in a variety of settings. A case-based learning approach will be used.
Topics & Faculty
- If You Can Treat Asthma, You Can Treat Tobacco Dependence: A Step Care Approach to Tobacco Dependence Treatment
Frank T. Leone, MD, FCCP, Philadelphia, PA
- Tobacco-Dependent Adolescents and Tobacco-Dependent Parents: Using the Tobacco Dependence Treatment Toolkit in the Pediatric Health-care Visit
Harold J. Farber, MD, FCCP Houston, TX
[back] |
